Korea Research Institute of Bioscience and Biotechnology

Lg Energy Solution, Ltd.

Silicon Works Co., Ltd.

Lg Chem, Ltd

Won Gon Kim

Baek Soo Han

Mi Jin Sohn

Jeong Su Byun

Ha Young Choi

Jin Hee Jeon

Ki Young Lee

Yu Jin Kim

Kwang Soo Kim

Jae Wan Kim

Kyu Ho Kim

Il Kwon Kim

Ki Suk Cho

Seung Jun Choi

Myoung Su Song

Kyoung Choon Min

Kyoung Shim Kim

Chun Hyung Kim

Hoe Yune Jung

Young Mi Kang

Hyun Ju Kim

Ki Young Kim

Chang Ji Zheng

Yun Ju Kwon

Kyung Yun Cho

Jin Yong Jeon

Van Minh Nguyen

The present invention relates to a pharmaceutical composition for preventing or treating neurodegenerative diseases comprising a diterpene, or a pharmaceutically acceptable salt thereof. Specifically, the diterpene of the present invention can prevent or treat neurodegenerative diseases caused by inhibition of Nurr1 activity by activating Nurr1 and inhibiting the inflammatory response.

Composition for preventing or treating neurodegenerative diseases, containing diterpene-based compound

A device and method for diagnosing an increase in resistance of a lead unit of a battery cell, including a first voltage measurement step in which when a battery pack is in an open circuit voltage state, a voltage is measured for each unit cell of the battery pack, a second voltage measurement step in which, when the battery pack is in a charging or discharging state, a voltage is measured for each unit cell according to a predetermined current flowing through the battery pack, and a step for comparing, for each unit cell, a voltage measured in the first voltage measurement step and a voltage measured in the second voltage measurement step, and detecting whether the unit cell is abnormal.

Battery cell diagnostic device and method

The present invention relates to a pharmaceutical composition and health functional food for preventing or treating neurodegenerative diseases which include a flower extract ofor fractions thereof as an active ingredient. The pharmaceutical composition and health functional food for preventing or treating neurodegenerative diseases are, not like extracts from stems and/or roots of, free from genotoxicity and have superior prophylactic or treatment effects against neurodegenerative diseases.

Pharmaceutical composition for preventing or treating neurodegenerative diseases which includes flower extract ofor fractions thereof as active ingredient

Disclosed are a communication method between a master controller and slave controllers, a slave controller for the communication method, and a battery management system using the communication method and the slave controller, in which the master controller receives safety information about battery cells through a plurality of channels even when each of a plurality of slave controllers includes only one micro controller unit, thereby minimizing the increase in the cost and enhancing the safety of the battery management system. The communication method includes performing bidirectional communication between a master controller and first to N(where N is an integer equal to or more than two) slave controllers through a first communication channel, and receiving, by the master controller, an indication signal through a second communication signal via the first to Nslave controllers.

Communication method between master controller and slave controller, slave controller for the same, and battery management system using the same

The present invention relates to: coralmycin A and B, which are novel compounds exhibiting antimicrobial activity, an isomer thereof, a derivative thereof or a pharmaceutically acceptable salt thereof; a microorganism of the genusproducing the same; and an antimicrobial use thereof. The coralmycin A and B have very strong antimicrobial activity against antibiotic-resistant bacteria such as MRSA, QRSA, VRE, VISA, etc.;, which is a multidrug-resistant microorganism; and also against gram-positive microorganisms and gram-negative microorganisms. Therefore, the present invention can be very useful for prevention, treatment and alleviation of various microbial infections, and thus can be widely applied to the medical supply, quasi-drug, food, and feed industries.

Antimicrobial compound and use thereof

Pharmaceutical composition for preventing or treating neurodegenerative diseases which includes flower extract of daphne genkwa or fractions thereof as active ingredient

Disclosed are a novel strain with antibacterial activity, identified assp. AN1542 strain (Accession No.: KCTC 12113BP), an antibacterial composition comprising a compound represented by Chemical Formula 1 or 2, or a strain producing the same as an active ingredient, and a method for producing the same. Exhibiting potent antibacterial activity against pathogenic microbes and antibiotic-resistant microbes, particularly, MRSA, QRSA, VRSA and VRE, the compound or the strain of the present invention can be applied to the treatment of infectious diseases caused by superbacteria.

Antifungal composition comprising polycyclic peptide compound and method for preparing the same

The present invention relates to a pharmaceutical composition for preventing or treating Parkinson's disease, which comprises, as an active ingredient, aextract obtained by extracting the stem ofwith an organic solvent, and a food additive showing the effect of preventing or treating Parkinson's disease, the food additive comprisingextract as an active ingredient. Theextracts of the present invention may prevent or treat Parkinson's disease without producing any particular side effects, and therefore can be widely used for more safely treating Parkinson's disease.

Composition containing jetbead extracts

The present invention relates to: a pharmaceutical composition or a Nurr1 activating composition for the prevention or treatment of a neurodegenerative disease or a disease induced by impaired Nurr1 function, wherein the composition comprises an active ingredient in the form of genkwanin N or yuanhuacine, aextract comprising one or more of the above compounds, or a fraction thereof; or a functional food additive for preventing or alleviating a neurodegenerative disease or a disease induced by impaired Nurr1 function, wherein the additive comprises genkwanin N or yuanhuacine, aextract comprising one or more of the above compounds, or a fraction thereof; and a method for the prevention or treatment of a neurodegenerative disease or a disease induced by impaired Nurr1 function, wherein the method comprises the step of administering the pharmaceutical composition.

[object Object]

The present invention relates to an antibacterial pharmaceutical composition comprising anextract, and aceriphyllic acid A and 3-oxo-12-oleanen-27-oic acid isolated therefrom. Theextract of the present invention, and aceriphyllic acid A and 3-oxo-12-oleanen-27-oic acid isolated therefrom have strong antibacterial activities against, methicillin-resistant, quinolone-resistantor, thereby being used for the prevention or treatment of pathogenic bacterial and resistant bacterial infections, cariogenic bacterial and acne bacterial infections.

Growing community of inventors

Daejeon, South Korea

Won Gon Kim